Adtran Holdings sees its Relative Strength Rating hit the elite 90-plus level.
Lemonade shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 75 to 89.
U.S. stocks are entering the new year with strong momentum after several years of solid gains. The rally has matured, but has not broken. Inflation has eased, growth expectations are improving, and ...
The new year opens with confidence after another strong stretch for U.S. stocks. Markets are coming off a third straight year of solid gains, supported by easing inflation, a steady economy and ...
As of Friday, Neuronetics, Inc.’s STIM share price has dipped by 5.28%, which has investors questioning if this is right time to buy.
As of Friday, March 13, Applied Optoelectronics, Inc.’s AAOI share price has dipped by 5.21%, which has investors questioning ...
The Vanguard High Dividend Yield ETF is best held, not bought, as its current yield lags lower-risk alternatives. VYM's appeal lies in its diversified, quality portfolio and relative outperformance ...